Data Obtained by Univariate Survival Analysis
| Characteristics . | No. . | Deaths Due to ALCL . | 5-yr Survival3-150 (%) . | P Values3-151 . |
|---|---|---|---|---|
| % GrB+ cells | ||||
| <15 | 21 | 3 | 90 | .0006 |
| ≥15 | 21 | 13 | 37 | |
| ALK status | ||||
| Negative | 29 | 16 | 45 | .001 |
| Positive | 13 | 0 | 100 | |
| IPI | ||||
| Low | 22 | 3 | 85 | <.0001 |
| Low-intermediate | 9 | 4 | 65 | |
| High-intermediate | 5 | 5 | 0 | |
| High | 6 | 4 | 35 | |
| B symptoms | ||||
| No | 21 | 5 | 75 | .03 |
| Yes | 21 | 11 | 50 | |
| Age | ||||
| ≤60 years | 31 | 10 | 70 | NS |
| >60 years | 11 | 6 | 40 | |
| Stage | ||||
| I | 9 | 2 | 75 | NS |
| II | 12 | 2 | 80 | |
| III | 9 | 6 | 45 | |
| IV | 12 | 6 | 50 | |
| Extranodal sites | ||||
| 0-1 | 32 | 11 | 65 | NS |
| >1 | 10 | 5 | 50 | |
| LDH level | ||||
| ≤1 × normal | 27 | 6 | 75 | .004 |
| >1 × normal | 14 | 9 | 40 | |
| Performance status | ||||
| 0-1 | 29 | 7 | 75 | .0002 |
| 2-4 | 13 | 9 | 25 |
| Characteristics . | No. . | Deaths Due to ALCL . | 5-yr Survival3-150 (%) . | P Values3-151 . |
|---|---|---|---|---|
| % GrB+ cells | ||||
| <15 | 21 | 3 | 90 | .0006 |
| ≥15 | 21 | 13 | 37 | |
| ALK status | ||||
| Negative | 29 | 16 | 45 | .001 |
| Positive | 13 | 0 | 100 | |
| IPI | ||||
| Low | 22 | 3 | 85 | <.0001 |
| Low-intermediate | 9 | 4 | 65 | |
| High-intermediate | 5 | 5 | 0 | |
| High | 6 | 4 | 35 | |
| B symptoms | ||||
| No | 21 | 5 | 75 | .03 |
| Yes | 21 | 11 | 50 | |
| Age | ||||
| ≤60 years | 31 | 10 | 70 | NS |
| >60 years | 11 | 6 | 40 | |
| Stage | ||||
| I | 9 | 2 | 75 | NS |
| II | 12 | 2 | 80 | |
| III | 9 | 6 | 45 | |
| IV | 12 | 6 | 50 | |
| Extranodal sites | ||||
| 0-1 | 32 | 11 | 65 | NS |
| >1 | 10 | 5 | 50 | |
| LDH level | ||||
| ≤1 × normal | 27 | 6 | 75 | .004 |
| >1 × normal | 14 | 9 | 40 | |
| Performance status | ||||
| 0-1 | 29 | 7 | 75 | .0002 |
| 2-4 | 13 | 9 | 25 |